Mergers and Acquisitions - Shijia Photon plans to acquire equity in Dongguan Fuke Xima Communications Technology Co., Ltd. through a combination of issuing shares and cash payment, with the transaction price yet to be finalized [1] - Jifeng Technology intends to purchase a 5.29% stake in Sichuan Jifeng Juli Industrial Development Co., Ltd. for 7.1625 million yuan, aiming for 100% ownership post-transaction [2] - Jingce Electronics has completed the signing of an agreement to acquire approximately 4.83% of Shanghai Jingce Semiconductor Technology Co., Ltd. for 183 million yuan from the National Integrated Circuit Industry Investment Fund [3] Earnings Disclosure - Sairisi expects a net profit of 2.7 billion to 3.2 billion yuan for the first half of 2025, representing a year-on-year increase of 66.20% to 96.98% [4] - WuXi AppTec anticipates a revenue of approximately 20.799 billion yuan for the first half of 2025, with an adjusted net profit of about 6.315 billion yuan, reflecting a year-on-year growth of approximately 44.43% [5] - Guosheng Financial Holdings projects a net profit of 150 million to 220 million yuan for the first half of 2025, indicating a year-on-year increase of 236.85% to 394.05% [6] Shareholding Changes - Baoshui Technology announced that Shengbang Kaimi plans to reduce its stake by up to 1%, equivalent to a maximum of 12.0015 million shares, between August 4 and November 3 [7] - Wantong Development reported that shareholder Beijing Fuyuan intends to reduce its holdings by up to 3%, or 57.5074 million shares, through various trading methods [8] - Xingsen Technology's controlling shareholder plans to reduce its stake by up to 1.5%, approximately 25.344 million shares, within three months following the announcement [9]

2025.07. 10 7月10日晚间，沪深两市多家上市公司发布公告，以下是第一财经对一些重要公告的汇总，供投资者 参考。 【品大事】 塞力医疗：旗下联营企业治疗性降压疫苗项目试验能否成功还存在重大不确定性 塞力医疗(603716)发布股票交易异常波动公告，公司股票连续3个交易日内日收盘价格涨幅偏离值累 计超过20%，属于股票交易异常波动的情形。公司关注到近期市场对创新药业务关注度较高。公司 旗下联营企业华纪元生物是公司于2020年1月投资的参股公司，持有其15.61%的股份，投资金额 1066.6万元，华纪元生物2024年营业收入2.68万元，净利润-238.23万元。其治疗性降压疫苗项目 HJY-ATRQβ-001已完成概念验证（POC）阶段研究和临床前研究，已于2025年6月6日获得国家药 监局（NMPA）的新药临床试验申请（IND）受理，后续还需经一期、二期临床试验，试验能否成功 还存在重大不确定性。上述投资目前对公司主营业务的影响较小，敬请投资者注意相关风险，理性决 策，审慎投资。 人福医药：股东招商生科取得增持股份专项贷款承诺函 人福医药(600079)公告，公司近日收到股东招商生命科技（武汉）有 ...

Core Viewpoint - Multiple listed companies in the Shanghai and Shenzhen markets have released important announcements, highlighting significant developments and performance forecasts that may impact investor decisions [1]. Company Announcements - **Saili Medical**: The therapeutic hypertension vaccine project by its affiliate, Huajiyuan Biotechnology, faces significant uncertainty despite recent market interest in innovative drugs. The company holds a 15.61% stake in Huajiyuan, which reported a revenue of 26,800 yuan and a net loss of 2,382,300 yuan for 2024 [3]. - **Renfu Pharmaceutical**: Shareholder,招商生科, has secured a loan commitment of up to 750 million yuan from招商银行武汉分行 to increase its stake in Renfu Pharmaceutical. The planned share buyback will occur within six months starting from July 3, 2025, with a maximum purchase price of 25.53 yuan per share [4]. - **China Merchants Energy Shipping**: The company has received a new multi-purpose heavy-lift vessel, "Mingshi," as part of its order for four eco-friendly vessels. The fleet now includes 102 operational bulk carriers, with 16 vessels on order for future delivery [5]. - **Shangwei New Materials**: The company announced a significant stock price fluctuation, with a 30% increase over two days. A share transfer agreement was signed, potentially changing the controlling shareholder to Zhiyuan Hengyue, pending shareholder approval [6]. - **Northern Rare Earth**: The trading price for rare earth concentrates has been adjusted to 19,109 yuan per ton for Q3 2025, based on market conditions [7]. - **Baotou Steel**: Similar to Northern Rare Earth, Baotou Steel has proposed an adjustment of the rare earth concentrate trading price to 19,109 yuan per ton for Q3 2025 [9]. - **Shanghai Mechanical & Electrical**: The company received approval from the Shanghai State-owned Assets Supervision and Administration Commission for the transfer of 51.137 million shares from its controlling shareholder, Shanghai Electric, without changing control [10]. Performance Forecasts - **Eyer Communication**: The company expects a net profit of approximately 463 million yuan for the first half of 2025, a year-on-year increase of about 121.13%, driven by growth in the IoT sector [12]. - **Tianbao Infrastructure**: The company forecasts a net profit of 90 million to 130 million yuan for the first half of 2025, representing a year-on-year increase of 1581.8% to 2329.27% due to tax recoveries [13]. - **China Shipbuilding**: The expected net profit for the first half of 2025 is between 2.8 billion and 3.1 billion yuan, reflecting a year-on-year increase of 98.25% to 119.49% due to improved production efficiency and order structure [14]. - **Shanghai Xiba**: The company anticipates a net profit of 99 million to 118 million yuan for the first half of 2025, a year-on-year increase of 136.47% to 181.85%, primarily due to non-recurring income [15]. - **Longyuan Technology**: The expected net profit for the first half of 2025 is between 26 million and 31 million yuan, reflecting a year-on-year increase of 116.61% to 158.26% [16]. - **Zhengbang Technology**: The company forecasts a net profit of 190 million to 210 million yuan for the first half of 2025, marking a return to profitability driven by increased pig sales [17][18]. - **Bolong Technology**: The expected net profit for the first half of 2025 is between 22 million and 28 million yuan, a year-on-year increase of 123.09% to 183.93% due to successful project deliveries [19]. - **Haitou Shares**: The company anticipates a net profit of approximately 380 million yuan for the first half of 2025, a year-on-year increase of about 233.10% due to favorable market conditions [20]. - **Chuangjiang New Materials**: The expected net profit for the first half of 2025 is between 24 million and 29 million yuan, reflecting a year-on-year increase of 42.35% to 72% [21]. - **Hudian Shares**: The company forecasts a net profit of between 1.65 billion and 1.75 billion yuan for the first half of 2025, a year-on-year increase of 44.63% to 53.4% [22]. - **Taiping Bird**: The company expects a net profit of around 77.7 million yuan for the first half of 2025, a decrease of approximately 55% due to declining retail performance [23]. - **China Satellite**: The company anticipates a loss of between 21.2 million and 41.2 million yuan for the first half of 2025, attributed to reduced contract fulfillment and increased operational costs [24]. - **ST Yatai**: The company expects a loss of between 12.6 million and 20.9 million yuan for the first half of 2025, primarily due to cash flow issues and increased non-recurring expenses [25]. Major Contracts - **Bai Da Group**: The company signed a significant leasing contract for the Hangzhou Department Store, with a rental agreement of 375 million yuan per quarter, increasing by 4.5% every three years [26]. Shareholding Changes - **Baoshui Technology**: A major shareholder plans to reduce their stake by up to 1% through market transactions between August 4 and November 3, 2025 [28].

持股 5%以上股东减持股份计划公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： ? 大股东及董监高持股的基本情况 证券代码：600794 证券简称：保税科技 公告编号：2025-032 张家港保税科技（集团）股份有限公司 减持期间公司有送股、资本公积金转增股本、回购注销等股本变动事项的， 拟减持的比例不变，减持数量将根据公司总股本的变动进行相应调整。 一、减持主体的基本情况 | 股东名称 胜帮凯米 | | | | | | | --- | --- | --- | --- | --- | --- | | 控股股东、实控人及一致行动人 □是 √否 | | | | | | | 直接持股 5%以上股东 | | | √是 | □否 | | | 股东身份 | | | | | | | 董事、监事和高级管理人员 | | | | □是 | √否 | | 其他：无 | | | | | | | 持股数量 60,007,608股 | | | | | | | 持股比例 5.0000% | | | | | | | 当前持股股份 ...

证券代码：600794 证券简称：保税科技 公告编号：2025-032 张家港保税科技（集团）股份有限公司 持股 5%以上股东减持股份计划公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 大股东及董监高持股的基本情况 截至本公告披露日，上海胜帮私募基金管理有限公司－共青城胜帮凯米投资 合伙企业（有限合伙）（以下简称"胜帮凯米"）持有张家港保税科技（集团）股 份有限公司（以下简称"公司"）无限售条件流通股 60,007,608 股，占公司总股 本的 5.0000%。 减持计划的主要内容 胜帮凯米计划自 2025 年 8 月 4 日至 2025 年 11 月 3 日通过集中竞价交易方 式减持不超过 12,001,521 股，即不超过公司总股本的 1%。 减持期间公司有送股、资本公积金转增股本、回购注销等股本变动事项的， 拟减持的比例不变，减持数量将根据公司总股本的变动进行相应调整。 | 股东名称 | 胜帮凯米 | | | | --- | --- | --- | --- | | 股东身份 | 控股股东、 ...

保税科技(600794.SH)公告称，公司持股5%以上股东胜帮凯米计划自2025年8月4日至11月3日通过集中竞 价交易方式减持不超过1200万股，即不超过公司总股本的1%。减持期间公司有 送股、资本公积金 转增 股本等股本变动事项的，拟减持的比例不变，减持数量将根据公司总股本的变动进行相应调整。 ...

证券代码：600794 证券简称：保税科技 编号：临 2025-031 张家港保税科技（集团）股份有限公司 股票交易异常波动公告 本公司及董事会全体成员保证公告内容不存在虚假记载、误导性陈述或者重 大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 张家港保税科技（集团）股份有限公司（以下简称"公司"）股票于 2025 年 6 月 20 日、6 月 23 日连续两个交易日内收盘价格涨幅偏离值累计超过 20%，属于股票 交易异常波动。经公司自查，并向公司控股股东发函问询核实，确认不存在应披露 而未披露的重大信息。 一、股票交易异常波动的具体情况 经公司自查，并经向控股股东发函确认：截至本公告披露日，公司、控股股东 及实际控制人均不存在影响公司股票交易异常波动的重大事项，不存在应披露而未 披露的重大信息，包括但不限于重大资产重组、股份发行、收购、债务重组、业务 重组、资产剥离、资产注入、股份回购、股权激励、破产重整、重大业务合作、引 进战略投资者等重大事项。 二、公司关注并核实的相关情况 （三）媒体报道、市场传闻、热点概念情况 （一）生产经营情况 经公司自查，公司目前生产经营正常，内外部经营 ...

张家港保税科技(集团)股份有限公司: 张家港保税区金遴 |有限公司 2025 6月 23 贵司来函收悉,函告如下: 张家港保税区金港资产经营集团有限公司 关于保税科技股票交易异常波动的回复函 特此函复。 截至目前,本公司及股东不存在应披露而未披露的影响 贵司股价异常波动的重大信息,包括但不限于重大资产重组、 发行股份、上市公司收购、债务重组、业务重组、资产剥离 和资产注入等重大事项。 截至目前,本公司及股东无买卖贵司股票的行为。 ...

智通财经6月23日电，保税科技(600794.SH)发布异动公告，经自查，公司目前生产经营正常，内外部经 营环境未发生重大变化。公司、控股股东及实际控制人均不存在影响公司股票交易异常波动的重大事 项，不存在应披露而未披露的重大信息。公司股票价格于2025年6月20日、6月23日连续两个交易日内日 收盘价格涨幅偏离值累计超过20%，股价剔除大盘和板块整体因素后的实际波动幅度较大。敬请广大投 资者注意二级市场交易风险，理性决策，审慎投资。 2连板保税科技：生产经营正常 无应披露而未披露的重大事项 ...

Investment Rating - The report assigns an "Outperform" rating to the company with a target price of RMB 5.13, based on a 2.3x PB valuation for 2025 [1][14]. Core Insights - The company's revenue is projected to decline significantly in 2024, with an expected revenue of RMB 0.90 billion, down 40.0% YoY, and a net profit of RMB 0.21 billion, down 16.8% YoY, primarily due to decreased storage utilization at its subsidiary [15]. - Smart logistics is identified as a growth area, with revenue expected to reach RMB 0.22 billion in 2024, accounting for 24.3% of total revenue, and showing a 16.9% YoY increase [16]. - The traditional logistics segment maintains stable market share, with key products holding significant national import market shares of 36% and 47% for Ethylene glycol and Diethylene glycol, respectively [17]. Financial Summary - The company’s projected financials indicate a significant drop in revenue and net profit for 2024, with revenues of RMB 0.90 billion and net profits of RMB 0.21 billion [3][15]. - EPS forecasts for 2025-2027 are RMB 0.12, 0.14, and 0.16, with corresponding YoY growth rates of -34.0%, +17.4%, and +18.3% [14]. - The company’s net asset return is expected to decline to 5.2% in 2025, before gradually improving to 6.7% by 2027 [3].